Estimation of Salivary MMP-8, MMP-9, MMP-13 and TIMP-1 in Chronic Periodontitis in Mosul

Heba F. Hamodat¹ and Mahmoud Y.M. Taha^1,

¹Department of Dental Basic Science, College Of Dentistry, Mosul University, Iraq

Cite this paper:
Heba F. Hamodat and Mahmoud Y.M. Taha. Estimation of Salivary MMP-8, MMP-9, MMP-13 and TIMP-1 in Chronic Periodontitis in Mosul. International Journal of Dental Sciences and Research. 2020; 8(1):22-26. doi: 10.12691/ijdsr-8-1-4

Abstract

The aim of the study was to estimate salivary concentrations of MMP-8, MMP-9, MMP-13, and TIMP-1in chronic periodontitis and control patients, and correlate periodontal parameters with salivary biomarkers in chronic periodontitis patients. The study group consisted of 44 patients suffering from chronic periodontitis, aging between ≤ 16-45 years old and 40 control samples collected from healthy individuals ranged between 16-40 years old. Chronic periodontitis was assessed on the basis of several periodontal parameters, including probing pocket depth (PPD), clinical attachment loss (CAL), bleeding on probing (BOP) and plaque index (PI). 5ml of unstimulated saliva was collected from patients and control groups to measure salivary biomarkers by ELISA technique. All periodontal clinical parameters were significantly higher in chronic periodontitis patients compared to control group (p ≤ 0.000). Salivary MMP-8, MMP-9 and MMP-13 concentrations showed significant increase in chronic periodontitis (p ≤ 0.000), while salivary TIMP-1 level showed significant increase in control group comparing with periodontitis (p ≤ 0.000). Salivary MMP-13and MMP-9 showed significant difference in concentrations with different PPD, and CAL levels, while MMP-8 showed no significant difference, whereas all salivary biomarkers showed no significant difference with BOP index. According to Plaque index, MMP-8 concentration showed highly significant difference with different PI values.

Keywords:
Chronic periodontitis MMPs TIMP-1 periodontal parameters

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Mlachkova, AM., and Popova, CL. Efficiency of nonsurgical periodontal therapy in moderate chronic periodontal. J Folia Med. 56(2): 109-115. 2014.
[2]	Lepilahti, JM., Ahonen, M-M., Hernandez, M., Munjal, S., Netuschil, L., and Uitto, VJ. Oral rinse MMP-8 point of care immune test identifies patents with strong periodontal inflammatory burden. Oral Dis. 17: 115-122. 2011.
[3]	Armitage, G. C., and Cullinan, MP. Comparison of the clinical features of chronic and aggressive periodontitis. Periodontol 2000. 53: 12-27. 2010.
[4]	Newman, GM., Takei, HN., Carranza, FA., and EDS. Carranza Clinical Periodontology. Philidalphia. 12th ed. pp 96-112. 2015.
[5]	Janet. Oral fluid-based biomarkers of alveolar bone loss in periodontitis. Ann New York Acad. Sci. 1098: 230-251. 2007.
[6]	Amalinei, C., Caruntu, I. D., Giusca, S. E., and Balan, R. A. Matrix metalloproteinases involvement in pathological conditions. Rom J Morphol Embryol. 51,215-228. 2010.
[7]	Luo, K.w.; Wei, C., Lung, W.Y., Wei, X.Y., Cheng, B.H., Cai, Z.M., and Huang, W.R. EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivi via down-regulation of NK-ᵏB and MMP-9. J Nutr Biochem. 41: 56-64. 2016.
[8]	Stawoczyk, K. M., Weiienestein, M.D., Lee, S.B., Yomtoubian, S., Durrans, A., Choi, H., and Huang, W.RMatrix metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor. Neoplasia. 19: 55-64. 2016.
[9]	Shintani, T., Kusuhara, Y., Daizumoto, K., Dondoo, T.O., Yamamoto, H., Mori, H., Fukawa, T., Nakatsuuji, H., Fukumori, T., and Takahashi, M. The Involvement of Hepatocyte Growth Factor-MET-Matrix Metalloproteinase 1 Signaling in Bladder Cancer Invasiveness and Proliferation. Effect of the MET Inhibitor, Cabozantinib (XL184), on Bladder Cancer Cells. Urology. 2016.
[10]	Butler, G. S., and Overall, C. M. Update biological roles for matrix metalloproteinase and new "intracellular" substrate revealed by degradomics. Biochemistry. 48: 10830-10845. 2009.
[11]	Jackson, B. C., Nebert, D. W., and Vasiliou, V. Update of human and mouse matrix metalloproteinase families. Human Genomics. 4(3): 194-201. 2010.
[12]	Brew, K., and Nagase, H. The tissue inhibitors of metalloproteinases (TIMP): an ancient family with structural and functional diversity. Biochimica Biophysica Acta. 1803(1): 55-71. 2010.
[13]	Brew, k., Dinakarpandian, D., and Nagase, H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochimica Biophysica Acta. 1477(1-2), 267-283. 2000.
[14]	Sapna, G., Gokul, S., and Bagri-Manjrekar, K. Matrix metalloproteinases and periodontal diseases. Oral Dis. 20(6): 538-550. 2014.
[15]	Aurer A, Jorgić-Srdjak K, Plančak D, Stavljenić-Rukavina A, and Aurer-Koželj J. Pro inflammatory factors in saliva as possible markers for periodontal disease. Coll Antropol. 29(2) 435-439. 2005.
[16]	Khongkhunthian, S; Kongtawelert, P; Ongchai, S; Pothacharoen, P; Sastraruji, T; Jotikasthria, D and Krisanaprakornkit, S. Comparison between Two Biochemical Markers in Evaluating Periodontal Disease Severity: A Cross-Sectional Study. J of BMC Oral Health. 14-107. 2014
[17]	Lindhe, J; Karring, T and Niklans, P.L. Clinical Periodontology and Implant Dentistry. 5thEdition. Blackwell Munksgaard, a Blackwell Puplishing Company. Oxford. 2008.
[18]	Carranza, F.A. Clinical Periodontology. 10th Edition. WB Sounder Company; Philadelphia. 2009.
[19]	Newman, GM., Takei, HN., Carranza, FA., and EDS. Carranza Clinical Periodontology. Philidalphia. 12th ed. pp 96-112. 2015.
[20]	Zhang, L., Li, X., Yan, H., and Huang, L. Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA-compliant systemic review and meta-analysis. Medicine. 97(3). 2018.
[21]	Hernandez, M., Martinez, B., Tejerina, JM., Valenzuela, MA., and Gamonal, J. MMP-13 and TIMP-1 determinations in progressive chronic periodontitis. J Clin Periodontol. 34:729-735. 2007.
[22]	Uchida, M., Shima, M., Shimoaka, T., and Fujieda, A. Regulation of matrix metallproteinases (MMPS) and tissue inhibitors of metalloproteinases (TIMPs) by bone resorptive factors in osteoblastic cells. J Cell Physiol. 185:207-214. 2000.